Gemita 1400mg/87.5mg Injection
By Gemita
Rx
1 Injection in a Vial

Composition
Gemcitabine(1400mg) + Mannitol(87.5mg)

Manufacturer - Fresenius Kabi India Pvt Ltd
Fresenius Kabi AG"‹ , Else-Kröner-Straße 1 "‹ , 61352 Bad Homburg , Germany

Expires on or after
April, 2027

liver
Limited information is available regarding the use of Gemita 1400mg/87.5mg Injection in individuals with liver disease. It is advised to seek guidance from your doctor before using this medication to ensure safety and proper management of your condition.

kidney
Gemita 1400mg/87.5mg Injection is likely safe for patients with kidney disease. The existing data indicates that dose adjustment may not be necessary. Please consult your doctor for guidance.

alcohol
Gemita 1400mg/87.5mg Injection can cause severe drowsiness when combined with alcohol. It is advised to be cautious when consuming alcohol while using this injection.

driving
Gemita 1400mg/87.5mg Injection may reduce alertness, impact vision, or cause drowsiness and dizziness. It's advisable not to drive if you experience these effects.

pregnancy
Gemita 1400mg/87.5mg Injection is not safe to use during pregnancy. There is evidence of risk to the developing baby. Only in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor.

breastfeeding
Caution should be taken while breastfeeding as Gemita 1400mg/87.5mg Injection is considered unsafe and may cause toxicity to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI NEOPLASTICS |
| Action Class | - |
₹10317
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025
